CRISPR Eradicates Latent HIV-1, Offering Hope of “Functional Cures” – Genetic Engineering & Biotechnology News
|
CRISPR Eradicates Latent HIV-1, Offering Hope of “Functional Cures”
Genetic Engineering & Biotechnology News Scientists in Japan have used CRISPR-Cas9 technology to stop human immunodeficiency virus type 1 (HIV-1) replication in latently infected T cells that can’t be controlled using existing drug treatments. The gene-editing approach effectively disrupts … |
Drug Target Review |
CRISPR Eradicates Latent HIV-1, Offering Hope of “Functional Cures”
Genetic Engineering & Biotechnology News Scientists in Japan have used CRISPR-Cas9 technology to stop human immunodeficiency virus type 1 (HIV-1) replication in latently infected T cells that can’t be controlled using existing drug treatments. The gene-editing approach effectively disrupts … CRISPR used to destroy the regulatory genes of HIVDrug Target Review |
|
CRISPR Eradicates Latent HIV-1, Offering Hope of “Functional Cures”
Genetic Engineering & Biotechnology News Scientists in Japan have used CRISPR-Cas9 technology to stop human immunodeficiency virus type 1 (HIV-1) replication in latently infected T cells that can’t be controlled using existing drug treatments. The gene-editing approach effectively disrupts … |
News-Medical.net |
Researchers create tool to determine patient’s response to immunotherapy drugs
News-Medical.net The researchers said this model may help them to determine which patients may respond to checkpoint inhibitors, a class of immunotherapy drugs that “remove the brakes” that can keep the immune system from attacking cancer cells. Five checkpoint … |
|
Your Daily Pharma Scoop: Abeona Presents Strong Data, Glaxo Nucala Treatment Benefit, Rocket Pharma’s Gene …
Seeking Alpha Abeona presented strong data from ABO-102 targeting MPS III A. Glaxo’s asthma drug Nucala showed sustained treatment benefit in an open label study. Rocket Pharma’s gene therapy drug RP-L102 showed treatment benefit in an early stage study in … |
The Cheat Sheet |
Everything You Need to Know About Tarek El Moussa’s Controversial Stem Cell Treatment for His Back Pain
The Cheat Sheet This is the second time the reality star experienced a serious back injury, People reports. El Moussa, who also survived cancer twice, is desperate to regain his life and turned to a controversial stem cell treatment to relieve his anguish. This is … Flow of cerebrospinal fluid found to be key signal for neural stem cell renewalNews-Medical.net Global Plant Stem Cell For Cosmetics Market 2018 Outlook by 2023: LOreal, Mibelle, Estee Lauder, Juice BeautyBrooks in Beta (press release) (blog) Stem–Cell Based Bone Grafts Market Research Report: Know Marketing Channel Future Trend, Growth and Price with …Expert Consulting Exclusive Reportage –Digital Journal –CryptoNexa all 116 news articles » |
Asbestos.com |
Experts Discuss Unique Side Effects of Immunotherapy
Asbestos.com If you have mesothelioma and you’ve already received standard-of-care therapies, you may be considering an immunotherapy clinical trial. If you’re considering this option, a free immunotherapy teleconference is a great place to learn more. CancerCare … |